To study the effect of Agastya haritaki Avaleha in reccurent upper respiratory track infectio
Phase 2
- Conditions
- Health Condition 1: J069- Acute upper respiratory infection,unspecified
- Registration Number
- CTRI/2022/03/041164
- Lead Sponsor
- PLRD Hospial
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The cases of recurrent URTI with the features mentioned in the criteria of selection of patients shall be included
patients irrespective of sex occupation religion socio economic status and duration of illness
children aged between 3-12 years will be included for study
Recurrent URT infection with need of antibiotic for 3 times in last six months
Exclusion Criteria
patients above 12 years will be excluded from the study
patient with nasal anatomical abnormalities will be excluded
patient suffering from chronic systemic disease like tuberculosis and immuno compromised patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in symptoms like sneezing nasal discharge cough and fever by grading or scoring methodsTimepoint: Results are expected within a time period of 4 to 6 weeks
- Secondary Outcome Measures
Name Time Method Relief from symptoms like nasal discharge and cough with sputum by grading or scoring methodsTimepoint: Results expected in 45 to 60 days